Advertisement

Topics

Illumina Company Profile

14:36 EST 17th November 2017 | BioPortfolio

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our technology platform also extends to other applications such as high-throughput screening of pharmaceutical compounds and chemical detection.

Location

9390 Towne Centre Dr. Suite 200
San Diego
CA
92024
United States of America

Contact

Phone: 858 587 4297
Email: investor@illumina.com


News Articles [90 Associated News Articles listed on BioPortfolio]

5 interessante Dinge aus dem dritten Quartalsbericht von Illumina

Bei Illumina (WKN:927079) läuft es im Jahr 2017 gerade gut. Der Pionier im Bereich Gensequenzierung hat am Dienstag seine Ergebnisse für das dritte Quartal bekannt gegeben. Illumina übertraf erneut...

Illumina, Inc. (ILMN) Expected to Announce Quarterly Sales of $732.21 Million

Wall Street brokerages forecast that Illumina, Inc. will post sales of $732.21 million for the current quarter, according to Zacks Investment Research . Seven analysts have issued estimates for Illumi...

Helix, Illumina Partner to Support Startups for DNA-Driven Consumer Products

Personal genomics company Helix and Illumina are partnering to support consumer genomics startups. Helix is teaming up with Illumina Accelerator to provide resources and support for innovative entrepr...

Illumina -- LATEST 1

BIO's preferred Gene Sequencing Solutions provider, Illumina, offers a free learning opportunity with a recorded webinar, "Th -More- 

Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups

Genomics startups are increasing in number and quality, so much so that three-year-old Illumina Accelerator has expanded with its latest class to accommodate five of them. Xconomy got an early look at...

Illumina, Telegraph Hill Partners launch Verogen

Illumina announced plans with Telegraph Hill Partners (THP), a San Francisco-based venture capital and growth equity firm, to establish Verogen. The independent new company has certain exclusive right...

Illumina Ventures raises $230M for first fund investing in early stage startups targeting genomics

Illumina Ventures has invested in seven companies to date spanning genetic counseling support to targeted gene therapy.

Illumina’s NovaSeq Platform Targets the $100 Human Genome, but do they Risk Self-Cannibalisation?

Illumina utilised their showcase at the JP Morgan Conference to announce its new DNA sequencers, the NovaSeq 5000 and NovaSeq 6000, promising that by the end of the year the new machines

Drugs and Medications [0 Results]

None

PubMed Articles [47 Associated PubMed Articles listed on BioPortfolio]

Strategies for processing and quality control of Illumina genotyping arrays.

Illumina genotyping arrays have powered thousands of large-scale genome-wide association studies over the past decade. Yet, because of the tremendous volume and complicated genetic assumptions of Illu...

StrandScript: Evaluation of Illumina Genotyping Array Design and Strand Correction.

After the introduction of high-throughput sequencing, genotyping arrays continue to be a viable source for conducting large-scale genetic studies. Currently, Illumina is one of the largest genotyping ...

A novel post hoc method for detecting index switching finds no evidence for increased switching on the Illumina HiSeq X.

High throughput sequencing using the Illumina HiSeq platform is a pervasive and critical molecular ecology resource, and has provided the data underlying many recent advances. A recent study has sugge...

ChAMP: Updated Methylation Analysis Pipeline for Illumina BeadChips.

The Illumina Infinium HumanMethylationEPIC BeadChip is the new platform for high-throughput DNA methylation analysis, effectively doubling the coverage compared to the older 450K array. Here we presen...

Genome Sequencing of Steroid-Producing Bacteria with Illumina Technology.

Illumina technology is widely used for bacterial whole-genome sequencing due to its simplicity, cheapness, reliability, and abundant software for manipulation with raw data. Illumina technology belong...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Effect of Probiotics on Nasopharyngeal Microbiome of Children With Otitis Media With Effusion

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (nasopharynx, adenoids and middle ear fluid) of otitis media with effusion (OME) patients is c...

Epigenetic Biomarker for Osteosarcoma

hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based on selective chemical labeling. It uses β-glucosyltransferase (βGT) to selectively label 5hmC with a biotin vi...

Comprehensive DNA Methylation Profiling in Crohn's Disease

Previous studies have indicated that abnormal DNA methylation frequently occurs in the mucosa in Crohn's disease. Comprehensive DNA methylation profiling of the inflamed and non-inflamed i...

Microbiota Upper Respiratory Tract

The aim of this study is to investigate whether the microbiota in the upper respiratory tract (URT) (nose, nasopharynx and sinuses) of chronic rhinosinusitis (CRS) patients is disturbed co...

Genes-in-Action - Hepcidin Regulation of Iron Supplementation

Anaemia continues to be one of the most common health problems affecting children and pregnant women in low-income countries. Nutritional iron deficiency is believed to be the main driver ...

Companies [13 Associated Companies listed on BioPortfolio]

Illumina

Illumina develops tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics. Our tec...

Illumina Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and functi...

GRAIL

GRAIL is focused on detecting cancer at an early-stage, when it can be cured. The company secured over $100 million in Series A financing from Illumina, Inc. and ARCH Venture Part...

Illumina, Inc.

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and ...

bioMérieux & Illumina

More Information about "Illumina" on BioPortfolio

We have published hundreds of Illumina news stories on BioPortfolio along with dozens of Illumina Clinical Trials and PubMed Articles about Illumina for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Illumina Companies in our database. You can also find out about relevant Illumina Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record